190 related articles for article (PubMed ID: 33075188)
1. Breast Cancer-Specific Mortality in Small-Sized Tumor with Stage IV Breast Cancer: A Population-Based Study.
Zheng YZ; Wang XM; Fan L; Shao ZM
Oncologist; 2021 Feb; 26(2):e241-e250. PubMed ID: 33075188
[TBL] [Abstract][Full Text] [Related]
2. Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer.
Wo JY; Chen K; Neville BA; Lin NU; Punglia RS
J Clin Oncol; 2011 Jul; 29(19):2619-27. PubMed ID: 21606424
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer-specific mortality in small-sized tumor with node-positive breast cancer: a nation-wide study in Korean breast cancer society.
Ryu JM; Lee HJ; Yoon TI; Lee ES; Lee SJ; Jung JH; Chae BJ; Nam SJ; Lee JE; Lee SK; Bae SY; Yu J; Kim SW;
Breast Cancer Res Treat; 2016 Oct; 159(3):489-98. PubMed ID: 27590199
[TBL] [Abstract][Full Text] [Related]
4. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
5. Effect of tumor size on breast cancer-specific survival stratified by joint hormone receptor status in a SEER population-based study.
Zheng YZ; Wang L; Hu X; Shao ZM
Oncotarget; 2015 Sep; 6(26):22985-95. PubMed ID: 26036636
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
7. Effect of large tumor size on cancer-specific mortality in node-negative breast cancer.
Yu KD; Jiang YZ; Chen S; Cao ZG; Wu J; Shen ZZ; Shao ZM
Mayo Clin Proc; 2012 Dec; 87(12):1171-80. PubMed ID: 23218085
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of risk factors of axillary lymph node metastasis and prognosis in T1 breast cancer: a large-scale retrospective study based on the SEER database].
Wang WY; Meng XZ; Li N; Zeng HM; Liu JX; Feng KX; Wang PL; Wang X
Zhonghua Yi Xue Za Zhi; 2021 Jul; 101(27):2152-2158. PubMed ID: 34275251
[No Abstract] [Full Text] [Related]
9. Factors associated with late risks of breast cancer-specific mortality in the SEER registry.
Leone JP; Vallejo CT; Hassett MJ; Leone J; Graham N; Tayob N; Freedman RA; Tolaney SM; Leone BA; Winer EP; Lin NU
Breast Cancer Res Treat; 2021 Aug; 189(1):203-212. PubMed ID: 33893907
[TBL] [Abstract][Full Text] [Related]
10. Different patterns in the prognostic value of age for breast cancer-specific mortality depending on hormone receptor status: a SEER population-based analysis.
Liu YR; Jiang YZ; Yu KD; Shao ZM
Ann Surg Oncol; 2015 Apr; 22(4):1102-10. PubMed ID: 25249260
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of survival in small breast cancers.
Mustafa IA; Cole B; Wanebo HJ; Bland KI; Chang HR
J Am Coll Surg; 1998 May; 186(5):562-9. PubMed ID: 9583697
[TBL] [Abstract][Full Text] [Related]
12. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
13. Twenty-year risks of breast cancer-specific mortality for stage III breast cancer in the surveillance, epidemiology, and end results registry.
Leone JP; Leone BA; Tayob N; Hassett MJ; Leone J; Freedman RA; Tolaney SM; Winer EP; Vallejo CT; Lin NU
Breast Cancer Res Treat; 2021 Jun; 187(3):843-852. PubMed ID: 33590387
[TBL] [Abstract][Full Text] [Related]
14. Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
Tang C; Wang P; Li X; Zhao B; Yang H; Yu H; Li C
PLoS One; 2017; 12(8):e0182953. PubMed ID: 28806399
[TBL] [Abstract][Full Text] [Related]
15. Poorer breast cancer survival outcomes in males than females might be attributable to tumor subtype.
Wu Q; Li J; Zhu S; Wu J; Li X; Liu Q; Wei W; Sun S
Oncotarget; 2016 Dec; 7(52):87532-87542. PubMed ID: 27655704
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
17. Mortality Risks Over 20 Years in Men With Stage I to III Hormone Receptor-Positive Breast Cancer.
Leone J; Hassett MJ; Freedman RA; Tolaney SM; Graham N; Tayob N; Vallejo CT; Winer EP; Lin NU; Leone JP
JAMA Oncol; 2024 Apr; 10(4):508-515. PubMed ID: 38421673
[TBL] [Abstract][Full Text] [Related]
18. The effect of local therapy on breast cancer-specific mortality of women with occult breast cancer and advanced nodal disease (N2/N3): a population analysis.
Johnson HM; Irish W; Vohra NA; Wong JH
Breast Cancer Res Treat; 2019 Aug; 177(1):155-164. PubMed ID: 31127469
[TBL] [Abstract][Full Text] [Related]
19. The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer.
Wang R; Zhu Y; Liu X; Liao X; He J; Niu L
BMC Cancer; 2019 Nov; 19(1):1091. PubMed ID: 31718602
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis.
Chen SL; Hoehne FM; Giuliano AE
Ann Surg Oncol; 2007 Dec; 14(12):3378-84. PubMed ID: 17899293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
